Ubs Asset Management Americas Inc Ionis Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 285,697 shares of IONS stock, worth $9.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
285,697
Previous 320,290
10.8%
Holding current value
$9.34 Million
Previous $15.3 Million
25.02%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$492 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$463 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$337 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$285 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$257 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.64B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...